Inscription Capital, LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1767868 HOUSTON, TX

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$201,162

+$55,930 QoQ

Shares Held

13,750

+37.3% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#74

of 134 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 27% Shared 0% None 73%

Healthcare · as of Jun 30, 2026

Inscription Capital, LLC holds $1,295,045 across 5 Drug Manufacturers - Specialty & Generic names. ANIK ranks #4 (15.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	21,480	$344,324
2	ELAN	Elanco Animal Health Inc	13,042	$320,963
3	ZTS	Zoetis Inc.	4,057	$291,536
4	ANIK	Anika Therapeutics, Inc. This page	13,750	$201,162
5	BCRX	Biocryst Pharmaceuticals Inc	13,706	$137,060

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,162	13,750	+37.3%	Shares	Sole	2026-08-13
2026-03-31	$145,232	10,016	-20.9%	Shares	Sole	2026-04-20
2025-12-31	$121,720	12,666	—	Shares	Sole	2026-01-29
No filing history on record for this holder in this stock.